Seach Medical Group Yönetim
Yönetim kriter kontrolleri 4/4
Seach Medical Group's CEO is Yogev Sarid, appointed in Sep 2019, has a tenure of 5.17 years. total yearly compensation is ₪1.18M, comprised of 78.6% salary and 21.4% bonuses, including company stock and options. directly owns 18.97% of the company’s shares, worth ₪17.21M. The average tenure of the management team and the board of directors is 5.2 years and 5.2 years respectively.
Anahtar bilgiler
Yogev Sarid
İcra Kurulu Başkanı
₪1.2m
Toplam tazminat
CEO maaş yüzdesi | 78.6% |
CEO görev süresi | 5.2yrs |
CEO sahipliği | 19.0% |
Yönetim ortalama görev süresi | 5.2yrs |
Yönetim Kurulu ortalama görev süresi | 5.2yrs |
Son yönetim güncellemeleri
Recent updates
Seach Medical Group Ltd's (TLV:SEMG) 26% Price Boost Is Out Of Tune With Revenues
Oct 30Investors Still Aren't Entirely Convinced By Seach Medical Group Ltd's (TLV:SEMG) Revenues Despite 27% Price Jump
Aug 28Is Seach Medical Group (TLV:SEMG) A Risky Investment?
Aug 13Fewer Investors Than Expected Jumping On Seach Medical Group Ltd (TLV:SEMG)
Jun 02Is Seach Medical Group (TLV:SEMG) A Risky Investment?
Feb 21Is Seach Medical Group (TLV:SEMG) A Risky Investment?
Oct 12Seach Medical Group (TLV:SEMG) Has Debt But No Earnings; Should You Worry?
Jul 14Seach Medical Group (TLV:SEMG) Has A Pretty Healthy Balance Sheet
Feb 27Seach Medical Group Ltd's (TLV:SEMG) Share Price Not Quite Adding Up
May 13Seach Medical Group's (TLV:SEMG) Shareholders Have More To Worry About Than Lackluster Earnings
Dec 02Declining Stock and Decent Financials: Is The Market Wrong About Seach Medical Group Ltd (TLV:SEMG)?
Mar 18Seach Medical Group's(TLV:SEMG) Share Price Is Down 20% Over The Past Year.
Jan 22Has Seach Medical Group Ltd (TLV:SEMG) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Dec 18CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -₪12m |
Dec 31 2023 | ₪1m | ₪925k | -₪11m |
Sep 30 2023 | n/a | n/a | -₪5m |
Jun 30 2023 | n/a | n/a | -₪6m |
Mar 31 2023 | n/a | n/a | -₪3m |
Dec 31 2022 | ₪1m | ₪966k | -₪3m |
Sep 30 2022 | n/a | n/a | ₪6m |
Jun 30 2022 | n/a | n/a | ₪5m |
Mar 31 2022 | n/a | n/a | ₪3m |
Dec 31 2021 | n/a | n/a | ₪5m |
Sep 30 2021 | n/a | n/a | ₪7m |
Jun 30 2021 | n/a | n/a | ₪10m |
Mar 31 2021 | n/a | n/a | ₪13m |
Dec 31 2020 | ₪1m | ₪854k | ₪12m |
Tazminat ve Piyasa: Yogev's total compensation ($USD314.30K) is about average for companies of similar size in the IL market ($USD427.00K).
Tazminat ve Kazançlar: Yogev's compensation has been consistent with company performance over the past year.
CEO
Yogev Sarid (46 yo)
5.2yrs
Görev süresi
₪1,177,000
Tazminat
Mr. Yogev Sarid serves as Chief Executive Officer and Director at Seach Medical Group Ltd. since September 4, 2019. He holds MBA from Haifa University and BA in Agricultural Economics from the Hebrew Unive...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO & Director | 5.2yrs | ₪1.18m | 18.97% ₪ 17.2m | |
Chief Financial Officer | 5.2yrs | ₪1.05m | 0.67% ₪ 612.3k | |
Chief Operating Officer | 5.2yrs | ₪1.00m | Veri yok | |
CTO & Director | 5.2yrs | ₪999.00k | 18.97% ₪ 17.2m | |
Vice President of Sales & Trade | 2.7yrs | ₪890.00k | Veri yok | |
Vice President of Human Resources | 2.7yrs | Veri yok | Veri yok |
5.2yrs
Ortalama Görev Süresi
47.5yo
Ortalama Yaş
Deneyimli Yönetim: SEMG's management team is seasoned and experienced (5.2 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO & Director | 5.2yrs | ₪1.18m | 18.97% ₪ 17.2m | |
CTO & Director | 5.2yrs | ₪999.00k | 18.97% ₪ 17.2m | |
Independent Director | 5yrs | ₪55.00k | 0.019% ₪ 17.4k | |
Chairman of the Board | 5.1yrs | ₪400.00k | 0.22% ₪ 195.4k | |
Director | 5.1yrs | ₪130.00k | Veri yok | |
Independent External Director | 5.5yrs | ₪50.00k | Veri yok | |
Independent External Director | 5.5yrs | Veri yok | Veri yok |
5.2yrs
Ortalama Görev Süresi
53yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: SEMG's board of directors are considered experienced (5.2 years average tenure).